| ¿µ¹® | lymphoma | ÇÑ±Û | ¸²ÇÁÁ¾ |
|---|---|---|---|
| ¼³¸í | ¸²ÇÁÀý¿¡ »ý±ä ¾Ç¼º Á¾¾ç. ÀÌ ¾ÏÀº ¹éÇ÷º´°ú´Â ´Ù¸£´Ù. ¸²ÇÁ¼º ¹éÇ÷º´Àº °ñ¼ö¿¡¼ »ý±ä ¸²ÇÁ±¸¼º ¾Ç¼ºÁ¾¾çÀÌÁö¸¸, ¸²ÇÁÁ¾Àº ¸²ÇÁÀý¿¡¼ »ý±ä ¸²ÇÁ±¸¼º ¾Ç¼ºÁ¾¾çÀÌ´Ù. ¸²ÇÁÁ¾Àº Å©°Ô 2°¡Áö Áï È£ÁöŲ¸²ÇÁÁ¾(Hodgkin's lymphoma)°ú ºñÈ£ÁöŲ¸²ÇÁÁ¾(Non-Hodgkin's lymphoma)À¸·Î ³ª´¼ö ÀÖ´Ù. ¶ÇÇÑ ºñÈ£ÁîŲ¸²ÇÁÁ¾Àº ¿©·¯ °¡ÁöÀÇ ¼¼Æ÷ÇüÅ¿¡ µû¶ó ³ª´©°í ÀÖ´Ù. ÀÌ º´Àº ´ÜÁö ¸²ÇÁÀý»Ó¸¸ ¾Æ´Ï¶ó Áö¶ó, °ñ¼ö, ÀÌ¿Ü ´Ù¸¥ ±â°üÀ» ħ¹üÇÔÀ¸·Î½á ¾Ç¼ºÀ̸ç, »ý¸í¿¡ Å« À§ÇùÀ» ÁØ´Ù. ƯÀÌÇÑ ÇüÅ·Π¹öŶ¸²ÇÁÁ¾(Burkitt's lymphoma)°¡ ÀÖ´Ù. ÀÌ º´Àº ÁÖ·Î ¾î¸°ÀÌ¿¡°Ô ÀϾ¸ç ÁÖ·Î Áß¾Ó ¾ÆÇÁ¸®Ä«¿¡ ¸¹ÀÌ ¹ß»ýÇÑ´Ù. ¶ÇÇÑ ÀÌ º´Àº ¹ÙÀÌ·¯½º(Ebstein Barr virus)¿¡ ÀÇÇØ¼ ÀϾ´Â °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖ´Ù. ÁÖµÈ Ä§¹üºÎÀ§´Â ¾ó±¼ÀÇ ¾Æ·¡ÅλÀÀÌ´Ù. |
||
| ¿µ¹® | non-Hodgkin lymphoma | ÇÑ±Û | ºñÈ£ÁöŲ ¸²ÇÁÁ¾ |
|---|---|---|---|
| ¼³¸í | ¸²ÇÁÁ¾Àº ¸²ÇÁÀý¿¡ »ý±ä ¾Ç¼º Á¾¾çÀ¸·Î ¹éÇ÷º´°ú´Â ´Ù¸£´Ù. ¹éÇ÷º´Àº °ñ¼ö¿¡¼ »ý±ä ¸²ÇÁ±¸¼º ¾Ç¼ºÁ¾¾çÀÌÁö¸¸, ¸²ÇÁÁ¾Àº ¸²ÇÁÁ¶Á÷¿¡¼ »ý±ä ¸²ÇÁ±¸¼º ¾Ç¼ºÁ¾¾çÀÌ´Ù. Å©°Ô ¸²ÇÁÁ¾Àº 2°¡Áö·Î ³ª´ ¼ö ÀÖ´Â µ¥, È£ÁöŲº´(Hodgkin's lymphoma)°ú ºñÈ£ÁöŲ¸²ÇÁÁ¾(non-Hodgkin's lymphoma)À¸·Î ³ª´ ¼ö ÀÖ´Ù. ¶ÇÇÑ ºñÈ£ÁöŲ¸²ÇÁÁ¾Àº ¿©·¯ °¡ÁöÀÇ ¼¼Æ÷ÇüÅ¿¡ µû¶ó ³ª´©°í ÀÖ´Ù. ÀÌ º´Àº ´ÜÁö ¸²ÇÁÀý»Ó¸¸ ¾Æ´Ï¶ó Áö¶ó, °ñ¼ö, ÀÌ¿Ü ´Ù¸¥ ±â°üÀ» ħ¹üÇÔÀ¸·Î½á ¾Ç¼ºÀ̸ç, »ý¸í¿¡ Å« À§ÇùÀ» ÁØ´Ù. ¾Ç¼º¸²ÇÁÁ¾ÀÇ ÀÏÁ¾. ÀüÀÌÀÇ ÇüŰ¡ ´Ù¾çÇÏ¿©, ÁÖÀ§ ¸²ÇÁÀýÀ» °Ç³Ê¶Ù¾î ´Ù¸¥ ¸²ÇÁÀý·Î ÀüÀÌÇϱ⵵ ÇÑ´Ù. ¶ÇÇÑ ¼¼Æ÷ÀÇ ÇüÅ¿¡ µû¶ó ¿©·¯ °¡Áö Á¾·ù°¡ ÀÖÀ¸¸ç ´ë°³ Ä¡·á´Â ¹æ»ç¼±Ä¡·á¿Í ÈÇпä¹ýÀ» º¹ÇÕÇÏ¿© »ç¿ëÇÑ´Ù. |
||
| HL | hairline; hairy leukoplakia; half life; hearing level; hearing loss; heparin lock; histiocytic lymph... |
|---|---|
| NHL | nodular histiocytic lymphoma; non-Hodgkin lymphoma |
| DHL | diffuse histiocytic lymphoma |
| DPDL | diffuse poorly differentiated lymphocytic lymphoma |
| DUL | diffuse undifferentiated lymphoma |
| DHL | Diffuse 'histiocytic' lymphoma |
|---|---|
| DLBCL | Diffuse Large B-cell Lymphoma |
| DLBL | Diffuse large B cell lymphoma |
| HPV16 | human papillomavirus types 16 |
| HTLV-I/II | Human T cell lymphotropic virus types I and II |
| other-directed | Pertaining to a person readily influenced by the attitudes of others. (05 Mar 2000) |
|---|---|
| transferases (other substituted phosphate groups) | <enzyme> A class of enzymes that transfers substituted phosphate groups. Registry number: EC 2.7.8 (12 Dec 1998) |
| diffuse small cleaved cell lymphoma | <tumour> A diffuse poorly differentiated lymphocytic lymphoma; follicular centre cell lymphoma that lacks a follicular pattern; malignancy is of intermediate grade. (05 Mar 2000) |
| lymphoma, diffuse | Malignant lymphoma in which neoplastic cells diffusely infiltrate the entire lymph node without any definite organised pattern. Patients whose lymphomas present a diffuse pattern generally have a more unfavorable survival outlook than those presenting with a follicular or nodular pattern. (12 Dec 1998) |
| lymphoma, large-cell, diffuse | Malignant lymphoma composed of large cells which may be both cleaved and noncleaved. The pattern is predominantly diffuse. most of these lymphomas represent the malignant counterpart of B-lymphocytes at midstage in the process of differentiation. (12 Dec 1998) |
| lymphoma, mixed-cell, diffuse | A heterogeneous group of intermediate-grade lymphomas of mixed cellular composition. Although they have not been extensively studied, it appears that they are predominantly B-cell diseases. (12 Dec 1998) |
| lymphoma, small cleaved-cell, diffuse | An intermediate-grade malignant lymphoma in which the neoplastic cells (B-lymphocytes) exhibit variability in size, configuration, and degree of differentiation. The cells have distinctive nuclei, irregular in shape, with marked indentations and angularity. (12 Dec 1998) |
| point system test types | A near-vision test chart in which the various test types are multiples of a point (1/72 inch), lower-case letters being one-half the designated point size; reading 4-point at 16 inches is normal, and is designated N-4. (05 Mar 2000) |
| hydatiform mole: types | <radiology> Complete/classical mole, fertilization of an empty egg; diploid karyotype (paternal XX), no foetal parts; no chorionic membrane, 20% malignant complete mole with coexistent foetus (2%), molar degeneration of an identical twin partial mole, areas of molar change alternating with normal chorionic villi, triploid karyotype (66% XXY; 33% XXX), early onset of preeclampsia, foetal structures present (e.g., placenta), no malignant potential see: hydatiform mole (12 Dec 1998) |
| Snellen's test types | Square black symbols employed in testing the acuity of distant vision; the letters vary in size in such a way that each one subtends a visual angle of 5' at a particular distance. (05 Mar 2000) |
| stomach cell types | <radiology> Parietal (oxyntic), in fundus and body, may lead to HCl (acid) and intrinsic factor, chief, in fundus and body, may lead to pepsinogen, G-cells, in antrum, mucus? (12 Dec 1998) |
| oesophageal carcinoma: types | <radiology> Histologic types: squamous cell carcinoma (95%), adenocarcinoma (4%), 70% from Barrett oesophagus, carcinosarcoma = pseudosarcoma = spindle cell squamous cell carcinoma, usually middle 1/3 of oesophagus, large, polypoid, smooth, intramural mass; may be pedunculated, mucoepidermoid carcinoma, adenoid cystic carcinoma radiologic types: polypoid/fungating form (most common), sessile/pedunculated tumour with lobulated surface, applecore lesion, ulcerating form, infiltrating form, gradual narrowing with smooth transition (Differential diagnosis: benign stricture), varicoid form: superficial spreading carcinoma, thickened nodular tortuous longitudinal folds (Differential diagnosis: varices) (12 Dec 1998) |
| test types | Letters of various sizes used to test visual acuity. (05 Mar 2000) |
| Jaeger's test types | Type of different sizes used for testing the acuity of near vision. (05 Mar 2000) |
| cerebral sclerosis, diffuse | Diffuse progressive degeneration of the white matter of the brain, accompanied by mental deterioration, severe motor disturbances, and early death. (12 Dec 1998) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|